Search

everythinglearnresearchcommunity

for

Search:↓

Hura crepitans and its compound daphne factor F3 may help treat hair loss by blocking a specific hair growth inhibitor.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Follicular-unit grafting is an effective hair transplant method that looks natural and has a high success rate.

Hair transplantation and micrografting, used for baldness, involve moving hair follicles from hair-rich to bald areas, requiring careful procedure and post-care for success.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

Thread monofilament and minoxidil together increase hair growth in female androgenetic alopecia.

FUE megasession effectively treats severe hair loss with natural-looking results in one operation.

Actual harvested hair follicles were fewer and differed in type from estimated, with older patients and those with multiple transplants needing more careful planning.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Use minoxidil or finasteride first, then try HairMax LaserComb if needed.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Bobby Limmer was crucial in developing a hair transplant method that uses natural hair groupings for a more realistic look.

Metabolic syndrome reduces effectiveness of hair loss treatment.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Hair restoration combines drugs and follicular unit grafting for natural, long-lasting results.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Hair transplant using beard hair made acne scars on cheeks less visible with minimal scarring in the donor area.

New methods for growing skin cells can improve skin grafts by building blood vessels within them.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Exosomes show promise for future tissue regeneration.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

CD4+ skin cells may be precursors to basal cell carcinoma.

Docosahexaenoic acid (DHA) may help hair growth by promoting dermal papilla cell proliferation.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.